HomeAKBA • NASDAQ
add
Akebia Therapeutics Inc
Previous close
$1.30
Day range
$1.32 - $1.42
Year range
$0.78 - $2.48
Market cap
287.15M USD
Avg Volume
6.84M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 56.20M | 0.74% |
Operating expense | 97.52M | -42.26% |
Net income | 614.00K | 110.11% |
Net profit margin | 1.09 | 110.02% |
Earnings per share | 0.00 | 100.00% |
EBITDA | 12.36M | -65.65% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 42.92M | -52.55% |
Total assets | 241.70M | -32.12% |
Total liabilities | 272.29M | -22.39% |
Total equity | -30.58M | — |
Shares outstanding | 209.37M | — |
Price to book | -8.12 | — |
Return on assets | 3.10% | — |
Return on capital | 9.98% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | 614.00K | 110.11% |
Cash from operations | -2.31M | 95.78% |
Cash from investing | — | — |
Cash from financing | -1.29M | -128,900.00% |
Net change in cash | -3.60M | 93.42% |
Free cash flow | 12.94M | 1,070.55% |
About
Founded
Jan 1, 2007
Headquarters
Website
Employees
167